Dr. Edward Grendys, MD
Claim this profileFlorida Gynecologic Oncology
Studies Ovarian Cancer
Studies Adenocarcinoma
6 reported clinical trials
12 drugs studied
Area of expertise
1Ovarian Cancer
Stage III
Stage IV
BRCA1 positive
2Adenocarcinoma
Stage III
Stage IV
Stage II
Affiliated Hospitals
Clinical Trials Edward Grendys, MD is currently running
ACR-368
for Ovarian Cancer
This trial tests a new drug, ACR-368, alone or with a small dose of another drug, gemcitabine, in patients whose cancers don't respond to standard treatments. A special test helps decide which treatment might work best for each patient. Gemcitabine has been used with other drugs for various cancers, including pancreatic, lung, ovarian, and breast cancers.
Recruiting1 award Phase 1 & 210 criteria
Mirvetuximab + Bevacizumab
for Ovarian Cancer
GLORIOSA is a Phase 3 multicenter, open label study designed to evaluate the safety and efficacy of mirvetuximab Soravtansine as maintenance therapy in participants with platinum-sensitive ovarian, primary peritoneal or fallopian tube cancers with high folate receptor-alpha (FRα) expression.
Recruiting2 awards Phase 3
More about Edward Grendys, MD
Clinical Trial Related2 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Edward Grendys, MD has experience with
- ACR-368
- Gemcitabine
- Mirvetuximab Soravtansine
- Bevacizumab
- Artesunate Ointment
- Letrozole
Breakdown of trials Edward Grendys, MD has run
Ovarian Cancer
Endometrial Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Edward Grendys, MD specialize in?
Edward Grendys, MD focuses on Ovarian Cancer and Adenocarcinoma. In particular, much of their work with Ovarian Cancer has involved Stage III patients, or patients who are Stage IV.
Is Edward Grendys, MD currently recruiting for clinical trials?
Yes, Edward Grendys, MD is currently recruiting for 5 clinical trials in Fort Myers Florida. If you're interested in participating, you should apply.
Are there any treatments that Edward Grendys, MD has studied deeply?
Yes, Edward Grendys, MD has studied treatments such as ACR-368, Gemcitabine, Mirvetuximab Soravtansine.
What is the best way to schedule an appointment with Edward Grendys, MD?
Apply for one of the trials that Edward Grendys, MD is conducting.
What is the office address of Edward Grendys, MD?
The office of Edward Grendys, MD is located at: Florida Gynecologic Oncology, Fort Myers, Florida 33905 United States. This is the address for their practice at the Florida Gynecologic Oncology.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.